Earnings Call · Q1 FY2026·2026-05-13

Q1 26EPS +53.85%·Rev n/aQ4 25EPS -100.00%*·Rev n/aQ3 25EPS +4.17%·Rev n/aQ2 25EPS -25.00%·Rev n/a⚠ consensus missing

Insight Molecular Diagnostics Inc. IMDX

Gabrielle Woody — Investor Relations

Joshua Riggs — Chief Executive Officer

Andrea James — Chief Financial Officer

+25.9%1d on move date+25.1% vs SPY3d+24.5%5d+21.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IMDX calls or request research access.

More IMDX calls Browse calls Request research access